Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which contact lens gives sharper vision? new study puts two brands to the test

NCT ID NCT06475053

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares how well two types of daily disposable multifocal contact lenses work for people with nearsightedness (myopia). Researchers will measure things like sharpness of vision, reading ability, and eye coordination. About 30 people aged 9 to 30 who already wear contacts will take part. The goal is to see which lens provides better overall visual performance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
contact lens
What this could lead to
If successful, this study could show which lens design offers better vision for people with nearsightedness.
What could go wrong
This is a small, early-stage comparison with only 30 participants, so results may not apply to everyone. It does not test long-term safety or effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

9 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must satisfy the following conditions for inclusion in the trial: * Be between 9 and 30 years of age * Sign written Informed Consent/Assent. * Spherical Equivalent glasses prescription: -0.50 to -7.00 diopters (D), Astigmatism: ≤ -0.75D, Anisometropia: ≤ 1.00D * 20/20 vision in each eye * Existing contact lens wearer * An eye exam in last 9 months, normal stereoacuity on prior chart (or test if not available) * No known ocular disease - anterior or posterior (posterior determined by history/chart) * Have an acceptable or optimal fit with test lenses and be willing to wear these lenses as directed for the duration of the study. * On examination, have ocular findings considered to be within normal limits. * Be willing and able to follow instructions and attend the schedule of follow-up visits. Exclusion Criteria: * Any of the following will exclude a participant from this trial: * Current hard lens wearers * Using eye medication contraindicating lens wear such as daily use of artificial tears. * Eye injury or surgery within twelve weeks immediately prior to enrollment for this trial. * History of corneal refractive surgery * Currently enrolled in an ophthalmic clinical trial that could negatively impact corneal or conjunctival health in this trial. * Evidence of systemic or ocular abnormality, infection or disease likely to affect successful wear of contact lenses or use of their accessory solutions. * Allergy or sensitivity to any product used in this trial. * Pre-existing ocular condition that would contraindicate lens wear. * Any systemic disease including autoimmune disease, immunocompromising diseases, connective tissue disease, clinically significant atopic diseases, insulin dependent diabetes, use of medications including corticosteroids and antimetabolites that may affect the eye or be exaggerated by wearing contact lenses. * Lazy eye (Strabismus or amblyopia) * Pupil size \< 3.00 mm in either eye in dim light (measured at approximately 10 cd/m2 )

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Ohio State University College of Optometry

    Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.